Predictive Value of White Matter Hyperintensities for Early Neurological Deterioration in Patients with Embolic Stroke of Undetermined Source
Lihao Zhang,Yan Su,Qian Wang,Yan Wang,Yikun Guo
DOI: https://doi.org/10.2147/ndt.s472626
IF: 2.989
2024-10-30
Neuropsychiatric Disease and Treatment
Abstract:Lihao Zhang, 1 Yan Su, 2 Qian Wang, 1 Yan Wang, 1 Yikun Guo 1 1 Department of Neurology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, People's Republic of China; 2 Department of Radiology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, People's Republic of China Correspondence: Yikun Guo, Department of Neurology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, 68&num Middle Gehu Road, Changzhou, Jiangsu Province, 213000, People's Republic of China, Tel +86-519-81087079, Fax +86-519-81087711, Email Objective: To explore the role of white matter hyperintensities (WMH) in predicting early neurological deterioration (END) in patients with embolic stroke of undetermined source (ESUS) without reperfusion therapy. Methods: In a retrospective analysis, 111 acute ESUS patients not treated with reperfusion therapy were enrolled. WMH severity was evaluated using the Fazekas scale, with patients categorized into mild (Fazekas score ≤ 2) or moderate-to-severe (Fazekas score ≥ 3) WMH groups. Clinical data were compared between the groups, and END was monitored within 72 hours of hospital admission. The association between WMH and END was assessed using binary logistic regression. Results: Patients with moderate-to-severe WMH were significantly older (p = 0.001) and more likely to have a history of stroke (28.6% vs 10.5%, p = 0.017) compared to the mild WMH group. The END group (n=16) presented with higher baseline NIHSS scores and a greater prevalence of moderate-to-severe WMH (p < 0.05). Binary logistic regression identified moderate-to-severe WMH (OR = 4.012, 95% CI: 1.080– 14.906, p = 0.038), smoking (OR = 4.368, 95% CI: 1.171– 16.293, p = 0.028), and diabetes mellitus (OR = 3.986, 95% CI: 1.007– 15.789, p = 0.049) as independent predictors of END in ESUS patients. Conclusion: Moderate-to-severe WMH is an independent risk factor for END in ESUS patients not receiving reperfusion therapy, highlighting the importance of considering WMH in the clinical evaluation and management of stroke patients. Keywords: white matter hyperintensities, early neurological deterioration, embolic stroke of undetermined source, risk factors White matter hyperintensities (WMH) are a prominent neuroimaging finding associated with cerebral small vessel disease, typically appearing as bilateral and symmetrical hyperintensities on T2-weighted and fluid-attenuated inversion recovery (FLAIR) MRI sequences. 1 These WMH are not only a hallmark of microvascular pathology but also have been implicated in the pathogenesis of early neurological deterioration (END), a sudden exacerbation of neurological deficits in the acute phase of stroke that often foreshadows poor outcomes. 2–6 END is a complex phenomenon that has been linked to several underlying mechanisms, including hemodynamic abnormalities and inflammation. 7,8 These factors may contribute to the disruption of cerebral microcirculation, which is further reflected by the presence of WMH. The association between WMH and END in stroke patients underscores the importance of considering microvascular health in the overall management of stroke. Embolic stroke of undetermined source (ESUS) is a subtype of ischemic stroke that remains cryptogenic even after thorough diagnostic evaluation. 9 Characterized by an embolic pattern on neuroimaging, ESUS constitutes a significant proportion of all ischemic strokes and is associated with a relatively high annual recurrence rate despite the use of antithrombotic therapy. 10,11 This highlights the need for a better understanding of the underlying causes and risk factors for ESUS, particularly in relation to END. Given the limited research on the incidence and risk factors for END in ESUS patients, this study was designed to investigate the potential impact of WMH on the development of END in this specific patient population, excluding those who received reperfusion therapy. By exploring this relationship, the study aims to contribute to the body of knowledge on stroke outcomes and inform future therapeutic strategies that may mitigate the risk of END in patients with ESUS. Data for this study were retrieved from the stroke center database of Changzhou NO.2 People's Hospital, Jiangsu Province, China. This study was approved by the Clinical Research Ethics Committee of the Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University (2021KY312-01). A written informed consent was obtained from the patients or their legally authorized representatives. All methods were carried out in acco -Abstract Truncated-
psychiatry,clinical neurology